… risk of glucocorticoid accumulation and of adverse effects. The pathogenesis of these cataracts
… The patients in this study used high doses of inhaled glucocorticoids; nevertheless, they …

… to this risk relate to … cataract about 2-fold, and the degree of risk was clearly related to both
the current and cumulative lifetime dosages. Evidence for a relationship to nuclear cataracts …

… Current evidence is limited by multiple biases and lack of generalisability but suggests an
increased risk of BMD loss, respiratory infection and cataracts. Further studies are needed to …

… can contribute to increased intraocular pressure and increased risk of cataract formation. A
few studies have examined whether ICS can have similar effects. (See "Major adverse effects …

… Inhaled corticosteroids remain the most important therapy for chronic asthma in both adults
and children. As all inhaled corticosteroids … cataracts in young patients treated with inhaled …

… a new inhaled corticosteroid with claimed improved risk/benefit … evidence on risks and benefits
of inhaled corticosteroids and … such cataracts in patients receiving inhaled corticosteroids (…

… Corticosteroid eye drops bear, however, the greatest risk. The use of nasal or inhaled
corticosteroids … , provided that patients have no other risk factors such as a positive family history.8, …

… to higher risk of cataract formation with severity being measured through analyses of lens
photographs. However, there was no significant increase in the risk of cortical cataract with the …

… Although the use of systemic corticosteroids poses an increased risk for cataracts, it has …
cataract formation. The occurrence of posterior subcapsular cataracts with ICS and oral steroid …

… -sectional study 35 reported increased dose- and duration-dependent risks of inhaled
corticosteroids use for posterior cataract. These studies do not report on COPD patients alone. …